Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares (ZEPP) is a publicly traded Technology sector company. As of November 10, 2026, ZEPP trades at $2.52 with a market cap of $33.00M and a P/E ratio of 0.00. ZEPP moved +7.23% today. Year to date, ZEPP is -91.39%; over the trailing twelve months it is -91.16%. Its 52-week range spans $2.13 to $61.85. Analyst consensus is buy with an average price target of $43.86. Rallies surfaces ZEPP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ZEPP insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $2.52 |
| Market Cap | $33.00M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.10% |
| 52-Week High | $61.85 |
| 52-Week Low | $2.13 |
| Volume | 420 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover ZEPP: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $43.86.